BioSpace News Archive

Phase III interim data on the first eight PNH patients who were all transfusion dependent at entry to the CAPSTONE trial show that all four patients randomized to nomacopan were transfusion independent for the first six months of treatment while all four patients on standard of care (SOC) remained transfusion dependent

Company to Present at the 38th Annual J.P. Morgan Healthcare Conference

Kramer Levin Naftalis & Frankel LLP today launched the Bio Law Blog, which provides insights into intellectual property law and regulatory developments for biologic medicines

Indapta Therapeutics, Inc., a biotechnology company focused on developing and commercializing a proprietary, first-in-class, off-the-shelf, non-engineered, allogeneic G-NK (FcRγ-deficient Natural Killer) cell therapy to treat multiple cancers, and Lonza today announced a strategic partnership

Dr. Africa Wallace, a board certified thoracic surgeon, has joined Capital Health Surgical Group and is now part of the nationally accredited Capital Health Cancer Center, located at Capital Health Medical Center - Hopewell.

BW Therapeutics, Inc. announced today the opening of its Series A fundraising process and kick-off of a strategic partnering initiative

On Tuesday, January 14th, 2020, New England Biolabs (NEB®) will be hosting a workshop to present the latest advances in next generation sequencing (NGS) sample preparation at the upcoming Plant and Animal Genome (PAG) Meeting, taking place January 11-15, 2020 in San Diego, California.

AVVie GmbH (“Angel Valve”) completed the 90 days chronic animal safety trial for the Mitral Butterfly® device for degenerative mitral regurgitation.

Three-Day Event Will Galvanize Thought Leaders, Researchers and Community Members Around Topics That Will Change the Culture and Reality of Paralysis

Wayne State University President M. Roy Wilson announced the appointment of Mark Schweitzer, M.D., as dean of the university’s School of Medicine and vice president of Health Affairs for the university..